Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Bioterrorism -- Ignore unavailable to you. Want to Upgrade?

To: Biomaven who wrote (249)	10/17/2001 4:15:19 PM
From: Ben Wa	Read Replies (1) \| Respond to of 891

Titan Creates HomeLand Security Office Focused On Chemical and Biological Terror -- /FROM PR NEWSWIRE LOS ANGELES 213-626-5500/ TO BUSINESS AND MEDICAL EDITORS: Titan Creates HomeLand Security Office Focused On Chemical and Biological Terrorism SAN DIEGO, Oct. 17 /PRNewswire/ -- The Titan Corporation (NYSE: TTN) today announced that the company has created the Homeland Security Office within the Office of the Chairman to specifically focus on providing solutions to chemical and biological terrorism. The Honorable Susan Golding, former Mayor of San Diego, a Board Member of both the SureBeam Corporation (Nasdaq: SURE) and Titan, and consultant to Titan CEO Gene Ray, will serve as the head of this office. The objective of the office is to efficiently bring together the combined resources of Titan and SureBeam, in order to provide government and commercial customers with comprehensive integrated solutions to the bioterrorism threat. As a first step, Titan and SureBeam will be offering SureBeam's proprietary electron beam technology as an immediate and safe solution for eliminating anthrax contamination from the U.S. mail. "I welcome the opportunity to bring together the significant technological capabilities of both Titan and SureBeam to address what has become an urgent national priority, chemical and biological terrorism. I look forward to working with the employees of both Titan and SureBeam to develop comprehensive solutions to this very serious problem facing our nation," said Susan Golding. For the past eight years, Titan/SureBeam electron beam technology has been used by Titan to sterilize and eliminate the threat of bacterial contamination in medical products, and for the last 18 months it has been used by SureBeam to eliminate dangerous bacteria in food. Similar to a microwave oven, the SureBeam(R) technology, which was originally developed by Titan, uses commercial electricity as its energy source to eliminate bacterial threats. Titan/SureBeam technology can electronically zap the mail or other packaging that may be used by a terrorist to transmit the anthrax, eliminating in minutes that threat or any other bacterial threats. Since Titan/SureBeam technology is a machine, it can be installed in almost any processing facility. There are presently four company-owned Titan or SureBeam electron beam facilities in operation and available, with facilities in Chicago, College Station, located at Texas A&M, and Los Angeles opening within the near future. Titan and SureBeam are currently using the technology to ensure the security of its own mail. For more than twenty years, Titan Systems has been providing a variety of information technology systems and services to the U.S. military and other government customers. Key areas of expertise include chemical and biological hazard prediction modeling, facility vulnerability assessments, and chemical and biological decontamination. SureBeam is a leading provider of electron beam food safety systems and services for the food industry. SureBeam's technology significantly improves food quality, prolongs shelf life, and provides disinfestation that helps to protect the environment. The SureBeam(R) patented system is based on proven electron beam and x-ray technology that destroys harmful food borne bacteria much like thermal pasteurization does to milk. This technology can also eliminate the need for toxic chemical fumigants used in pest control that may be harmful to the earth's ozone layer. Titan Scan Technologies, a wholly owned subsidiary of Titan, has been a premier leader in building and operating customized medical sterilization systems. Besides operating three medical sterilization facilities itself, the company has installed the systems in numerous medical equipment production facilities, domestically and abroad, to eliminate the threat of bacterial contamination. Headquartered in San Diego, The Titan Corporation creates, builds and launches technology-based businesses, offering innovative technical solutions. Three of Titan's four core businesses develop and deploy communications and information technology solutions and services. In addition, Titan's subsidiary SureBeam (Nasdaq: SURE) markets the leading technology for the electronic pasteurization of food products and Titan is continually identifying promising technologies suitable for commercialization. The company has approximately 8,000 employees and annualized sales of approximately $1.1 billion. "Safe Harbor" Statement under the Private Securities Litigation Reform Act of 1995: The statements contained in this release, which are not historical facts, are forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Examples of such forward-looking statements include the expectation that the Company will offer a solution to bioterrorism through the mail. These statements are subject to risks and uncertainties that could cause actual results to differ materially from those set forth in or implied by forward- looking statements. These risks and uncertainties include the risks associated with the Company's entry into new businesses and new markets and other risks described in the Company's Securities and Exchange Commission filings. Media Contact: Wil Williams, Vice President Corporate Communications (858) 552-9724 or wwilliams@titan.com Investor Relations Contact: Rochelle Bold, Vice President Investor Relations (858) 552-9400 or invest@titan.com If you would like to receive press releases via electronic mail, please contact invest@titan.com Press Releases and other Titan information are available on The Titan Corporation's World Wide Web site: titan.com